Abstract
JBS, which calls itself the world’s largest protein company, is taking a majority stake in the Spanish cell-based meat firm BioTech Foods. The $100 million investment will include a plant in Spain and a research center in Brazil, where JBS is based. JBS expects the Spanish plant to reach commercial production by 2024 and plans to eventually add a plant at the R&D center. While this is JBS’s first foray into cultivated meat, which is grown from animal cells, competitors Tyson and Cargill have made similar investments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
